Guided Therapeutics, Inc.
GTHP
$0.25
$0.0525.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.22M | -742.00K | -809.00K | -427.00K | -652.00K |
| Total Depreciation and Amortization | 28.00K | 27.00K | 27.00K | 25.00K | 24.00K |
| Total Amortization of Deferred Charges | 55.00K | 54.00K | 68.00K | 67.00K | 38.00K |
| Total Other Non-Cash Items | 366.00K | 160.00K | 272.00K | -10.00K | -17.00K |
| Change in Net Operating Assets | 478.00K | 224.00K | 273.00K | 14.00K | 275.00K |
| Cash from Operations | -291.00K | -277.00K | -169.00K | -331.00K | -332.00K |
| Capital Expenditure | 0.00 | -2.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -2.00K | -- | -- | -- |
| Total Debt Issued | 125.00K | 63.00K | 355.00K | 205.00K | 200.00K |
| Total Debt Repaid | -197.00K | -125.00K | -71.00K | -147.00K | -209.00K |
| Issuance of Common Stock | 307.00K | 260.00K | -- | -- | 535.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 32.00K | -17.00K | -45.00K | -- | 0.00 |
| Cash from Financing | 267.00K | 181.00K | 239.00K | 58.00K | 526.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.00K | -98.00K | 70.00K | -273.00K | 194.00K |